Try GOLD - Free
PlasmaGen secures ₹150 cr to expand into global markets
Mint Kolkata
|December 23, 2025
Biopharmaceutical company PlasmaGen Biosciences raised ₹150 crore in a new round of equity financing, valuing the firm at more than ₹1,500 crore.
ViNS Bioproducts, a specialty biopharma company, picked up a minority equity stake in PlasmaGen and led the round with participation from existing investors and other pharma companies and family offices.
PlasmaGen will use the new funds to take its business international. The company has identified distribution partners in “key” export markets.
Back home, the company plans to double down on its presence with its current portfolio of plasma-derived therapeutics. The company’s key products include albumin, intravenous immunoglobulin, rabies immunoglobulin, hepatitis B immunoglobulin, and RhD immunoglobulin (anti-D) which it distributes to private hospitals and state hospitals in India.
This story is from the December 23, 2025 edition of Mint Kolkata.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Kolkata
Mint Kolkata
Modulus taps UBS for private credit biz
Modulus Alternatives Investment Managers hired a veteran banker from UBS Group AG to lead its private credit business, according to people familiar with the matter, as demand for talent in the sector heats up.
1 min
January 07, 2026
Mint Kolkata
What the Union budget must do to get private capex going again
Long-term tax and regulatory certainty would grant private businesses the confidence to take risks
3 mins
January 07, 2026
Mint Kolkata
Ten top video games to look forward to in 2026
From the long-awaited GTA VI to fresh horror, superhero and sci-fi epics, 2026 is shaping up to be a blockbuster year
3 mins
January 07, 2026
Mint Kolkata
TVs ward off smartphone threat with AI
Uber robotaxis are on their way in, in 2026—and other AI news this week
1 min
January 07, 2026
Mint Kolkata
Average crude import cost falls below $60/barrel to 5-year low
India’s average crude oil import cost fell below $60 a barrel on Monday, the lowest in nearly five years, despite global geopolitical upheavals and sanctions against three major suppliers—Iran, Russia and Venezuela.
1 mins
January 07, 2026
Mint Kolkata
A study in deductions: How the taxman spots anomalies
A guide to how the tax system’s algorithms are flagging mismatches in Form 16, AIS and ITRs
4 mins
January 07, 2026
Mint Kolkata
Natco challenges Novo Nordisk’s Semaglutide patent
Hyderabad-based Natco Pharma Ltd has filed a patent revocation petition before the Delhi high court against Danish drugmaker Novo Nordisk, which sells weight-loss drug semaglutide under Wegovy brand name.
1 mins
January 07, 2026
Mint Kolkata
MAGINOT LINE FALLACY AND THE COSTLY ILLUSION OF TIMING THE MARKET CYCLES
In the years between World War I and World War II, France built what it believed was an impenetrable defensive barrier—the Maginot Line.
2 mins
January 07, 2026
Mint Kolkata
Mid-sized startups ditch unicorn chase to go public earlier
A growing cohort of mid-sized companies is considering a much earlier entry into public markets, unlike the post-pandemic boom of 2021 when Indian startups stayed private as long as possible in pursuit of unicorn valuations.
1 min
January 07, 2026
Mint Kolkata
Mandatory hallmarking for silver eyed
After making gold hallmarking mandatory, the government is now preparing to extend it to silver, beginning with a pilot project in select districts, a senior government official said on Tuesday.
2 mins
January 07, 2026
Listen
Translate
Change font size